Do we think a fair estimate in value could be based on a multiplier of survival time compared to the existing medication Relivrio of 9 months and value of around $1B?
So if we get, say, 2 years survival the value of Monepantel (just for MND + minor side effects) should be around $2.6B
Based on SOI - 386,486,545
$2.60 = $1,004,865,017 MC
$5.20 = $2,009,730,034 MC
- Forums
- ASX - By Stock
- Ann: Investor webinar - Phase 1 MND Study Top-Line Results
Do we think a fair estimate in value could be based on a...
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 16.8¢ | $83.41K | 481.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 308148 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 357167 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 302271 | 0.170 |
8 | 343445 | 0.165 |
7 | 198000 | 0.160 |
4 | 512800 | 0.155 |
8 | 328999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 346167 | 6 |
0.185 | 182874 | 3 |
0.190 | 266905 | 5 |
0.195 | 233327 | 5 |
0.200 | 1065496 | 12 |
Last trade - 13.04pm 16/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |